These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 362630)

  • 1. Antibody and lymphocyte-mediated immunologic recipient versus donor reactions before and after human renal allotransplantation--a prospective study.
    Grunnet N; Kristensen T
    Transplant Proc; 1978 Sep; 10(3):531-3. PubMed ID: 362630
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-donor cell-mediated responses. Pretransplant lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) in kidney transplantation.
    Myburgh JA; Smit JA
    Transplant Proc; 1978 Jun; 10(2):425-7. PubMed ID: 354131
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of whole blood for antibody-dependent cell-mediated cytotoxicity in kidney patients.
    Dupont E
    Proc Eur Dial Transplant Assoc; 1977; 14():321-7. PubMed ID: 341133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant immune monitoring of donor-recipient compatibility.
    Thomas F; Thomas J; Mendez G; Lee HM
    Transplant Proc; 1978 Jun; 10(2):429-32. PubMed ID: 354132
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-donor antibody responses. Recipient presensitization and renal allograft survival.
    Keown P; Stiller CR; Sinclair NR; Fung M; McGirr D; Moseley P; Howson W; Ulan RA
    Transplant Proc; 1978 Jun; 10(2):459-62. PubMed ID: 354135
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-specific monitoring of transplant patients.
    Dossetor JB; Kovithavongs T; Schlaut J; Pazderka V; Liburd EM; Bettcher KB; Pazderka F
    Transplant Proc; 1979 Jun; 11(2):1235-6. PubMed ID: 382496
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic monitoring in cardiac transplantation.
    Devineni R; McKenzie N; Keown P; Stiller C; Hellstrom A; Banerjee D
    Transplant Proc; 1984 Dec; 16(6):1576-9. PubMed ID: 6239427
    [No Abstract]   [Full Text] [Related]  

  • 10. B-lymphocyte and kidney cell cross-reactive antibodies eluted from rejected human renal allografts.
    Mohanakumar T; Siegel W; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1979 Dec; 11(4):1896-8. PubMed ID: 394434
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic and prognostic value of donor-specific posttransplant immune responses: clinical correlates and in vitro variables.
    Stiller CR; Sinclair NR; McGirr D; Jevnikar A; Ulan RA
    Transplant Proc; 1978 Sep; 10(3):525-30. PubMed ID: 362629
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
    Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
    J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific antibodies in renal allograft recipients. A reevaluation of the 51Cr-release assays comparing fibroblast and lymphoid target cells.
    Halloran PF; Aprile M; Haddad G; Cunningham K; Robinette MA
    Transplantation; 1984 Apr; 37(4):356-8. PubMed ID: 6369664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic monitoring of marrow graft recipients following transplantation from HLA-identical siblings.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplant Proc; 1978 Sep; 10(3):535-6. PubMed ID: 362631
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic characterization of the rejection of the allogenic transplanted kidney in pigs with and without immunosuppression].
    Werner M; Keitel R; Schürer KD; Otto U; Klötzer B; Kothe W; Sauer H; Ambrosius H
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(5):279-92. PubMed ID: 3538686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant immunologic monitoring of the renal allograft recipient.
    Gailiunas P; Suthanthiran M; Person A; Strom TB; Carpenter CB; Garovoy MR
    Transplant Proc; 1978 Sep; 10(3):609-11. PubMed ID: 362644
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of reversibility of renal allograft rejection.
    Gailiunas P; Busch G; Person A; Carpenter CB; Garovoy MR
    Transplant Proc; 1979 Mar; 11(1):17-9. PubMed ID: 377625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.